Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Eye Infections Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The eye infections market size has experienced significant growth in recent years. It is anticipated to increase from $7.93 billion in 2025 to $8.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. This historical expansion can be linked to the high occurrence of conjunctivitis and keratitis, a rise in contact lens usage, increasing urban pollution, improved healthcare access, and the proliferation of ophthalmology clinics.
The eye infections market is anticipated to experience substantial growth in the coming years. It is projected to expand to $10.24 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.2%. This growth over the forecast period is primarily driven by factors such as the development of innovative antimicrobial eye drugs, an expanding aging population, an increase in digital eye strain incidents, enhanced access to ophthalmic care, and the proliferation of online pharmacies. Significant trends for the forecast period include a rising prevalence of bacterial and viral eye infections, greater utilization of prescription ophthalmic drugs, increasing awareness regarding early diagnosis and treatment, the expansion of online and retail pharmacy networks, and the creation of broad-spectrum ophthalmic therapies.
Get A Free Sample Report With In-Depth Market Insights:
Eye Infections Market Industry Drivers: What’s Behind The Revenue Growth?
The growing occurrence and widespread presence of eye-related disorders are expected to drive the eye infections market. These disorders encompass various ocular conditions, including illnesses like glaucoma, cataracts, and macular degeneration, alongside refractive issues such as myopia and hyperopia. The rise in individuals suffering from eye-related disorders stems from elements such as an aging demographic, evolving lifestyles, environmental influences, and insufficient diagnostic abilities that cause delays in identifying problems. Eye infections can exacerbate or initiate these disorders through inducing inflammation, damaging tissues, and compromising the eye’s inherent protective mechanisms, potentially resulting in complications like vision loss or persistent conditions. As an illustration, information from October 2024, provided by the World Health Organization, a health authority based in Switzerland, indicated that in 2023, surgical interventions for advanced trachoma were performed on 130,746 individuals, and 32.9 million received antibiotic treatments, achieving a worldwide coverage of 29%. Consequently, the escalating incidence and prevalence of eye-related disorders are set to propel the eye infections market in the foreseeable future.
Eye Infections Market Segment Landscape And Growth Outlook
The eye infections market covered in this report is segmented –
1) By Indications: Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye, Uveitis, Cellulitis, Ocular Herpes
2) By Drug Type: Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Conjunctivitis: Bacterial Conjunctivitis, Viral Conjunctivitis, Allergic Conjunctivitis
2) By Keratitis: Bacterial Keratitis, Viral Keratitis, Fungal Keratitis, Acanthamoeba Keratitis
3) By Endophthalmitis: Post-surgical Endophthalmitis, Post-traumatic Endophthalmitis, Endogenous Endophthalmitis
4) By Blepharitis: Anterior Blepharitis, Posterior Blepharitis
5) By Stye: Internal Stye, External Stye
6) By Uveitis: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis
7) By Cellulitis: Periorbital Cellulitis, Orbital Cellulitis
8) By Ocular Herpes: Herpes Simplex Keratitis, Herpes Simplex Conjunctivitis
Eye Infections Market Growth Trends Reshaping The Competitive Landscape
Major companies operating in the eye infections market are concentrating on devising innovative therapies, such as photodynamic therapy, to bolster treatment efficacy and mitigate side effects. Photodynamic therapy is a medical procedure that employs a light-sensitive drug, activated by specific light wavelengths, to pinpoint and eliminate abnormal or infected cells. For example, in December 2024, VisiRose Inc., a US-based clinical-stage biotechnology company, joined forces with Provectus Biopharmaceuticals Inc., a US-based pharmaceutical company, and Bascom Palmer Eye Institute, a US-based health center, to unveil Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This groundbreaking, non-invasive investigational treatment is designed for infectious keratitis and other severe eye infections. The RB PDAT presents a promising resolution to the escalating global issue of antimicrobial resistance (AMR), offering a broad-spectrum ocular treatment. This therapy is engineered to be safe, effective, and cost-efficient, thereby addressing the pressing requirement for novel treatments in this domain.
Eye Infections Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the eye infections market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck And Co Inc, AbbVie Inc., Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, Alcon Laboratories Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Santen Pharmaceuticals Co Ltd, Rohto Pharmaceutical Co Ltd, Alembic Pharmaceuticals Limited, Novaliq GmbH, Eyevance Pharmaceuticals LLC, Ocular Therapeutix, I-Med Pharma Inc., EyeGate Pharmaceuticals Inc
View The Full Eye Infections Market Report:
Eye Infections Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the eye infections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye infections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model






